Project Category : Cardiovascular

LATEST INDUSTRY PROJECTS IN CARDIOVASCULAR

Kalbitor - Treatment for Hereditary Angioedema
Kalbitor (ecallantide) is a drug developed by US-based Dyax Corp...

Darapladib - Selective Lp-PLA2 Inhibitor for Prevention of Atherosclerosis
Darapladib is a selective LpPLA2 inhibitor under development...

Pradaxa – Oral Direct Thrombin Inhibitor
Pradaxa (dabigatran etexilate) is a new oral anticoagulant under...

Prasugrel - Investigational Antiplatelet Agent
Originally discovered by Sankyo and Ube Industries, prasugrel...

TRA-SCH-530348
TRA-SCH 530348 is an oral antiplatelet drug under development...

Rasilez
The product of a joint development programme between Swiss companies...

Darapladib - Selective Lp-PLA2 Inhibitor for Prevention of Atherosclerosis,
ETC-216 - Phospholipid Therapy for Coronary Heart Disease (CHD) Patients,
Exanta - Oral Direct Thrombin Inhibitor for the Prevention and Treatment of Venous Thromboembolism,
Kalbitor - Treatment for Hereditary Angioedema,
Lipitor / Torcetrapib - Combination Therapy for the Management of Dyslipidaemia,
Multaq - Investigational Agent for the Treatment of Cardiac Arrhythmia,
Pradaxa – Oral Direct Thrombin Inhibitor,
Prasugrel - Investigational Antiplatelet Agent,
Rasilez – Innovative Treatment for Hypertension,
TRA-SCH-530348 -Oral Antiplatelet Agent,